| CAMPSQ17772 |
| Title : |
USCL-K1 |
| Source : |
Synthetic construct |
| PubMed : |
25069750 |
| Activity : |
Antibacterial |
| Gram Nature : |
Gram -ve, Gram +ve |
| Target : |
MIC [MIC at 4% BSA] for S. aureus ATCC 29213 = 8 [512], MRSA ATCC 33592 = 16 [512], MSSE CANWARD-2008 81388 = 4 [256], MRSE CAN-ICU 61589 = 4 [256], E. faecalis ATCC 29212 = 16 [512], E. faecium ATCC 27270 = 8 [512], S. pneumoniae ATCC 49619 = 64 [32], E. coli ATCC 25922 = 8 [512], E. coli CAN-ICU 61714 = 8 [512], E. coli CAN-ICU 63074 = 16 [512], E. coli CANWARD-2011 97615 = 8 [512], P. aeruginosa ATCC27853 = 16 [>512], P. aeruginosa CAN-ICU 62308 = 64 [512], P. aeruginosa CANWARD-2011 96846 = 32 [>512], S. maltophilia CAN-ICU 62584 = 256 [>512], A. baumannii CAN-ICU 63169 = 256 [>512], K. pneumoniae ATCC 13883 = 32 [>512] |
| Validated : |
Experimentally validated |
| Comment : |
Lipopeptides; N-terminal: C16; C-terminal: NH2 |
Sequence: |
KKKK |